Literature DB >> 22266275

The association between proinflammatory cytokine polymorphisms and cerebral palsy in very preterm infants.

Helena Kapitanović Vidak1, Tina Catela Ivković, Mladen Jokić, Radan Spaventi, Sanja Kapitanović.   

Abstract

Cerebral palsy (CP) is a nonprogressive motor disorder caused by white matter damage in the developing brain and is often accompanied with cognitive and sensory disabilities. The risk of CP is higher among infants born preterm than in more mature infants. Intrauterine infection/inflammation, activation of the cytokine network and elevated levels of proinflammatory cytokines in neonatal blood or in amniotic fluid to which the preterm infant is exposed, has been identified as the most common cause of preterm delivery, periventricular leukomalacia (PVL) and CP. The aim of our study was to evaluate the possible association of four TNFα promoter single nucleotide polymorphisms (SNPs) (-1031 T/C, -857 C/T, -308 G/A and -238 G/A), two IL1β SNPs (-511 C/T and +3954 C/T) and one IL6 (-174 C/G) polymorphism with susceptibility to CP in very preterm infants. Statistically significant association between TNFα -1031 T/C high expression genotypes (TC and CC) (OR, 2.339; p=0.016) as well as between TNFα -1031 C high expression allele (OR, 2.065; p=0.013) and risk of CP was observed. In addition, statistically significant association was found between TNFα TC, CC, GG, GG -1031/-857/-308/-238 genotypes combination (OR, 3.286; p=0.034) and risk of CP. Statistically significant association between IL1β TT, CC -511/+3954 genotypes combination and risk of CP (OR, 4.000; p=0.027) was also found. In CP patients with cystic PVL (cPVL) statistically significant association was found between TNFα -1031 T/C high expression genotypes (TC and CC) (OR, 2.361; p=0.038), IL1β -511 C/T high expression genotype TT (OR, 3.215; p=0.030) as well as IL1β -511 T high expression allele (OR, 1.956; p=0.019) and risk of CP. Statistically significant association was also found in patients with cPVL between TNFα TC, CC, GG, GG -1031/-857/-308/-238 genotypes combination (OR, 4.107; p=0.024), as well as IL1β TT, CC -511/+3954 genotypes combination (OR, 7.333; p=0.005) and risk of CP. Our results suggest the role of TNFα and IL1β polymorphisms which have previously been associated with higher circulating levels of these cytokines in genetic susceptibility to white matter damage and consequently CP in very preterm infants. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266275     DOI: 10.1016/j.cyto.2011.12.018

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  19 in total

1.  Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth.

Authors:  Erin A S Clark; Steven J Weiner; Dwight J Rouse; Brian M Mercer; Uma M Reddy; Jay D Iams; Ronald J Wapner; Yoram Sorokin; Fergal D Malone; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Donald J Dudley; Steve N Caritis
Journal:  Am J Perinatol       Date:  2018-03-06       Impact factor: 1.862

2.  Genetic and epigenetic factors and early life inflammation as predictors of neurodevelopmental outcomes.

Authors:  Kirsi S Oldenburg; T Michael O'Shea; Rebecca C Fry
Journal:  Semin Fetal Neonatal Med       Date:  2020-05-15       Impact factor: 3.926

3.  COX-1 and COX-2 polymorphisms in susceptibility to cerebral palsy in very preterm infants.

Authors:  Helena Kapitanović Vidak; Tina Catela Ivković; Zoran Vidak; Sanja Kapitanović
Journal:  Mol Neurobiol       Date:  2016-01-19       Impact factor: 5.590

4.  The breadth and type of systemic inflammation and the risk of adverse neurological outcomes in extremely low gestation newborns.

Authors:  Karl C K Kuban; T Michael O'Shea; Elizabeth N Allred; Raina N Fichorova; Tim Heeren; Nigel Paneth; Deborah Hirtz; Olaf Dammann; Alan Leviton
Journal:  Pediatr Neurol       Date:  2014-10-16       Impact factor: 3.372

5.  Influence of interleukin 17 A and 17 F polymorphisms in keratoconus.

Authors:  Isabela Bronchtein Gomes; Christiane Maria Ayo; Alessandro Garcia Lopes; Laurie Sayuri Kumano; Geraldo Magela de Faria Junior; Gildásio Castello de Almeida; Lilian Castiglioni; Luiz Carlos de Mattos; Cinara Cássia Brandão
Journal:  Mol Biol Rep       Date:  2021-09-23       Impact factor: 2.316

6.  Relationship Between TNF-α and the Risk of Cerebral Palsy: A Systematic Review and Meta-Analysis.

Authors:  Baotian Wang; Fan Wang; Xiaoyan Xu; Li Yang; Jing Zhu; Jinjing Yuan; Jiulai Tang
Journal:  Front Neurol       Date:  2022-06-13       Impact factor: 4.086

Review 7.  Dysregulation of multiple signaling pathways: A possible cause of cerebral palsy.

Authors:  Jyoti Upadhyay; Mohd Nazam Ansari; Abdul Samad; Ashutosh Sayana
Journal:  Exp Biol Med (Maywood)       Date:  2022-03-07

8.  Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries.

Authors:  Sylvie Girard; Hugues Sébire; Marie-Elsa Brochu; Sinziana Briota; Philippe Sarret; Guillaume Sébire
Journal:  Brain Behav Immun       Date:  2012-09-13       Impact factor: 7.217

9.  TNF-α and MTHFR Polymorphisms Associated with Cerebral Palsy in Chinese Infants.

Authors:  Ruiying Hou; Xiuyu Ren; Juan Wang; Xujun Guan
Journal:  Mol Neurobiol       Date:  2015-12-08       Impact factor: 5.590

10.  Systemic inflammation and cerebral palsy risk in extremely preterm infants.

Authors:  Karl C K Kuban; T Michael O'Shea; Elizabeth N Allred; Nigel Paneth; Deborah Hirtz; Raina N Fichorova; Alan Leviton
Journal:  J Child Neurol       Date:  2014-03-18       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.